Naritaka Tamaoki

Background

About Naritaka Tamaoki

An accomplished and innovative scientist with over 18 years of experience in academic and biotech sectors, with extensive expertise in cellular reprogramming, including iPSC technology and rejuvenation of tumor-infiltrating lymphocytes (TILs) for effective adoptive cell therapy (ACT). Passionate about bridging basic and translational research, with a strong focus on T cell-based cancer immunotherapy. Shines when tackling complex research challenges that require problem-solving and critical thinking. Leading a team at Lyell to develop novel strategies for T cell rejuvenation through transient cellular reprogramming. Skilled in leveraging automated systems to optimize culture conditions for enhanced rejuvenation. Successfully organized and led cross-functional projects, contributing to the development and patenting of T cell rejuvenation technologies. Demonstrated strong leadership and team-building abilities by promoting collaboration, aligning goals, and conducting regular performance evaluations.